The obtained data elucidated that miR‐30b‐5p could target and repress EZH2 expression in NSCLC, indicating that miR‐30b‐5p may participate in NSCLC progression by targeting EZH2 in vitro. This evidence concerns the gene EZH2 and non-small cell lung carcinoma.